Navigation Links
Poorly Controlled Asthma Can Boost Chances of Pregnancy Complications
Date:8/11/2011

THURSDAY, Aug. 11 (HealthDay News) -- Pregnant women with poorly controlled asthma are at increased risk for pregnancy complications and for having a low-birth weight or premature baby, a new study warns.

Researchers reviewed data from 1975 to 2009 on more than 1 million pregnant women. Pregnant women with poorly controlled asthma were 50 percent more likely to develop preeclampsia (high blood pressure during pregnancy) and 25 percent more likely to have a premature baby.

Infants born to mothers with asthma weighed an average of 0.2 lbs. less at birth than those born to mothers without asthma.

The study was published in the British Journal of Obstetrics and Gynecology.

"The findings are significant and call for women with asthma to be more closely monitored during pregnancy," study leader Dr. Christina Chambers, a professor of pediatrics at the University of California San Diego and program director of the non-profit California Teratogen Information Service (CTIS) Pregnancy Health Information Line, said in a CTIS news release.

"It would be advisable for women on regular medications for asthma or having frequent symptoms to be monitored at least monthly during the course of their pregnancies," she suggested.

More information

The American Academy of Asthma, Allergy & Immunology provides an overview of asthma, allergies and pregnancy.

-- Robert Preidt

SOURCE: California Teratogen Information Service, news release, Aug. 9, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. AGH Study Shows High Rates of Poorly Controlled Asthma Among Inner-City Pittsburgh Children
2. Long-acting beta-agonists most effective step-up therapy for children with poorly controlled asthma
3. Poorly understood cell plays role in immunity against the flu
4. Older people in assisted-living facilities sleep poorly
5. Poorly presented risk statistics could misinform health decisions
6. HbA1C test for glucose monitoring poorly predictive in dialysis patients
7. Women, elderly, minorities poorly represented in lung cancer drug trial data submitted to US FDA
8. Special Needs Kids Bullied More, Fare Poorly at School
9. Poorly controlled asthma costly
10. Almac Launches New STEMS System to Transform Temperature Controlled Shipment Monitoring in Clinical Trials
11. Lacosamide validated as promising therapy for uncontrolled partial-onset seizures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 24, 2017 , ... If you are thinking of a visit to San ... architecture, October is the perfect time to visit. , Business Architecture Associates is pleased to ... offering for individuals, as a 4-½ day package for individuals, and as 4-½ day corporate ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... ... most prominent for-profit and nonprofit hospitals and health systems in the nation and ... around their institutions, led professional organizations and been instrumental in developing successful hospital ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dymedix® Diagnostics, ... sensors, announced today it had completed the first phase of building a global ... and rest of world (ROW) authorized dealers specializing in polysomnography accessories. The ...
(Date:5/23/2017)... ... May 23, 2017 , ... Allegheny Health Network and ... Joy D’Achille Center for Women’s Behavioral Health at West Penn Hospital , a ... for women suffering from pregnancy-related depression. Construction of the Center is underway with ...
(Date:5/23/2017)... ... 23, 2017 , ... New England Journal Of Medicine Confirms Viability of Rory’s ... -The Rory Staunton Foundation Calls on Health & Human Services, Tom Price to Adopt ... http://www.rorystauntonfoundation.org ) today reported on a new study released on May 21, 2017 in ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... N.Y. , May 22, 2017  Lilac ... treatment Gene-Eden-VIR/Novirin, announces the launch of a ... English, the results of a clinical study that ... year treatment with Gene-Eden-VIR/Novirin in individuals suffering from ... to note that there are no other treatments ...
(Date:5/15/2017)... Enterin Inc., a privately-held CNS pharmaceutical company based in ... Parkinson,s disease (PD), has enrolled the first patient in the ... multicenter study involving patients with PD and taking place at ... 9-to-12-month period. The first stage is open label and involves ... include Denver , Boca Raton ...
(Date:5/10/2017)... -- The Corporate Whistleblower Center says, "We are urging ... to call us anytime at 866-714-6466 if they possess ... a substantial scheme to overbill Medicare. We are ... of a medical equipment company if their employer ... practice groups with extra generous incentives to use, or ...
Breaking Medicine Technology: